Have mutation, will travel: utilizing online patient communities and new trial strategies to optimize clinical research in the era of molecularly diverse oncology
- PMID: 22334010
- DOI: 10.1097/JTO.0b013e3182432646
Have mutation, will travel: utilizing online patient communities and new trial strategies to optimize clinical research in the era of molecularly diverse oncology
Comment on
-
ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.J Thorac Oncol. 2009 Dec;4(12):1450-4. doi: 10.1097/JTO.0b013e3181c4dedb. J Thorac Oncol. 2009. PMID: 20009909
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
